Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
2 NC counties are under alert, including Johnston County.
Breaking News
Food truck hit by gunfire in Raleigh
Program
It's time for football! Tune to WRAL-TV to catch all the Week 1 highlights on Football Friday
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Structure Therapeutics Inc. - American Depositary Shares
(NQ:
GPCR
)
39.79
+0.64 (+1.63%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
365,729
Open
38.91
Bid (Size)
38.28 (5)
Ask (Size)
40.50 (1)
Prev. Close
39.15
Today's Range
38.83 - 40.27
52wk Range
26.61 - 75.02
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Promising Biotech Stocks for the Long-Term: August 2024
August 13, 2024
Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Here are just a few.
Via
InvestorPlace
GPCR Stock Earnings: Structure Therapeutics Beats EPS for Q2 2024
August 09, 2024
GPCR stock results show that Structure Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Performance
YTD
-1.49%
-1.49%
1 Month
+9.77%
+9.77%
3 Month
+7.37%
+7.37%
6 Month
-1.78%
-1.78%
1 Year
+39.42%
+39.42%
More News
Read More
Structure Therapeutics Reports Second Quarter 2024 Financial Results and Recent Highlights
August 08, 2024
From
Structure Therapeutics Inc.
Via
GlobeNewswire
3 Biotech Stocks That Could Make Your Summer Unforgettable
July 30, 2024
Via
InvestorPlace
Missed Out on Eli Lilly? These 2 Healthcare Stocks Have Big Catalysts on the Horizon.
July 22, 2024
Via
The Motley Fool
Peering Into Structure Therapeutics's Recent Short Interest
July 15, 2024
Via
Benzinga
Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review
July 19, 2024
Via
Investor's Business Daily
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 17, 2024
Via
Benzinga
Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?
July 17, 2024
Via
Benzinga
ASML Reports Q2 Results, Joins Spirit Airlines And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
July 17, 2024
Via
Benzinga
The 3 Most Undervalued Biotech Stocks to Buy in July 2024
July 12, 2024
Via
InvestorPlace
Eli Lilly Stock Leads in GLP-1 Race with its Triple Agonist Drug
July 09, 2024
Via
MarketBeat
Altimmune Stock: Is Its GLP-1 Drug the Next Ozempic Killer?
July 03, 2024
Via
MarketBeat
Exposures
Product Safety
Pfizer Stock is Ready to Stage a Turnaround on GLP-1 Hopes
July 02, 2024
Via
MarketBeat
The 3 Smartest Biotech Stocks to Buy With $5K Right Now
June 28, 2024
Via
InvestorPlace
Could Structure Therapeutics Become the Next Novo Nordisk?
June 17, 2024
Via
The Motley Fool
Gilead Sciences Jumps After Its Weight-Loss Drug Emerges From Under The Radar
June 14, 2024
Via
Investor's Business Daily
Structure Therapeutics Stock Could Rocket 87% Higher, According to 1 Wall Street Analyst. Is It Time to Buy?
June 11, 2024
Via
The Motley Fool
Skye Bioscience Pivots To Obesity After Glaucoma Flop; Shares Plummet
June 10, 2024
Via
Investor's Business Daily
Structure Therapeutics' Stock Is Soaring on the Promise of Its Wegovy Competitor, but Is It a Buy?
June 09, 2024
Via
The Motley Fool
Top Names Performance Update - Saturday, June 8
June 08, 2024
Via
Talk Markets
Week In Review: Structure Reports Efficacy Of Obesity Drug; Raises $476 Million
June 08, 2024
Via
Talk Markets
Structure Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional American Depositary Shares
June 07, 2024
From
Structure Therapeutics Inc.
Via
GlobeNewswire
Structure Therapeutics Announces Pricing of Upsized $476 Million Public Offering
June 05, 2024
From
Structure Therapeutics Inc.
Via
GlobeNewswire
The 3 Most Undervalued Biotech Stocks to Buy in June 2024
June 04, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.